This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%)...
All content for Centeno-Schultz Clinic - Podcasts is the property of Centeno-Schultz Clinic Staff and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%)...
Can You Get Injured or Killed from a Bad Upper Cervical injection?
Centeno-Schultz Clinic - Podcasts
59 minutes
1 month ago
Can You Get Injured or Killed from a Bad Upper Cervical injection?
Dr. Centeno reviews why social media posts touting "upper cervical injections" can be dangerous and how to avoid that danger. https://youtube.com/live/i-a1djjgBHA There was a problem with the slides not advancing, so here's another version of this talk: https://youtu.be/pOMQmdkdUDk
Centeno-Schultz Clinic - Podcasts
This episode of the CCI Deep Dive Podcast examines one of the most aggressively marketed—and most misunderstood—areas in regenerative medicine: umbilical cord, amniotic, and placental “stem cell” products. Drawing from published scientific investigations, the discussion breaks down why many of these birth-derived products do not contain functional living stem cells despite bold clinical claims. The episode walks listeners through the hard data, the extremely low viability rates (35–75%)...
